For following the competition: what moved in each program, several studies read as one move.
- povetacicept
- zuberitamab
- inebilizumab
- + 8 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Glomerulonephritis, Membranous to watchlistEvery Monday by email · turn it off any timePro · free during the beta